Institutional Research Policy

Abstract

AHRI was initially established to investigate the pathogenesis and human immune responses to leprosy. But now, it undertakes medical research in a wide range of diseases such as tuberculosis, malaria, NTDs, HIV and other viruses, antimicrobial resistance, as well as various cancers and other non-communicable conditions. In 2022, as a result of Proclamation Number 1263/2021 issued for the Definition of Powers and Duties of Executive Organs of the Federal Democratic Republic of Ethiopia, the mandate of the research institute is expanded by including responsibilities related with research, development and production of vaccines, diagnostics, therapeutics, traditional medicine, nutraceutical and other pharmaceuticals. The Institute further continues to be responsive to the challenges of emerging and reemerging diseases through medical research and innovation.